Huang Dennis Karl
SEC CIK 1641217 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | See Remarks | 147.8K | — | $262.3K | 13 | 2021-10-14 | 2026-04-16 |
Most active insiders at RARE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Horn Howard | CFO | — | $1.33M |
| 2 | KAKKIS EMIL D | Pres, CEO, Dir | — | $1.24M |
| 3 | Parschauer Karah Herdman | EVP, CLO | — | $487.9K |
| 4 | Harris Erik | EVP, Chief Commercial Off | — | $240.3K |
| 5 | Pinion John Richard | See Remarks | — | $228.7K |
| 6 | Crombez Eric | EVP, Chief Medical Off | — | $168.8K |
| 7 | SULIMAN SHEHNAAZ | Dir | — | $144.2K |
| 8 | Huizenga Theodore Alan | SVP, CAO | — | $59.8K |
| 9 | Sanders Corazon (Corsee) D. | Dir | — | $50.1K |
| 10 | Ray Amrit | Dir | — | — |
| 11 | Huang Dennis Karl | See Remarks | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-20 17:17 | 2026-04-16 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +23.1K | 147.8K | +19% | $0 |
| 2026-03-03 | 2026-03-02 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | F - Tax | $23.39 | -999 | 124.7K | -0.8% | -$23.4K | |
| 2026-03-03 | 2026-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +11.1K | 125.7K | +10% | $0 | |
| DM | 2025-03-04 | 2025-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +32.9K | 97.5K | +51% | $0 |
| D | 2025-03-04 | 2025-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | F - Tax | $42.92 | -1,348 | 114.6K | -1% | -$57.9K |
| DM | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +18.8K | 83.5K | +29% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | F - Tax | $53.69 | -470 | 83.0K | -0.6% | -$25.2K |
| DM | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +24.7K | 53.7K | +85% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | S - Sale | $45.65 | -389 | 75.3K | -0.5% | -$17.8K |
| D | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | D - Sale to Iss | $45.65 | -10.6K | 64.7K | -14% | -$483.8K |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | S - Sale | $66.62 | -3,234 | 36.9K | -8% | -$215.4K |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +14.0K | 51.0K | +38% | $0 |
| 2021-10-18 | 2021-10-14 | RARE | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl | EVP, Chief Tech Ops Off | S - Sale | $81.14 | -358 | 40.1K | -0.9% | -$29.0K |
Purchase Sale Sale after option exercise All abbreviations